Hannia Campos Núñez Departamento de Salud Pública HSPH Blg ...

Hannia Campos Núñez
Cargo Actual
Departamento de Salud Pública
HSPH Blg 1, Rm 201
665 Huntington Ave, Boston, MA 02111
Tel. 00 1 617 432 – 0100
Fax 00 1 617 432 -02435
hcampos@hsph.harvard.edu
• Catedrática de Nutrición, Escuela de Salud Pública, Universidad
de Harvard.
Educación
• 1984 B.A. en Biología, Mount Holyoke College, Boston, MA.
• 1987 M.S. en Ciencias Nutricionales, Universidad de Tufts,
Boston, MA.
• 1990 Ph.D. en Ciencias Nutricionales, Universidad de Tufts,
Boston, MA.
Formación Post-doctoral
• 1990-1993 Becaria en Investigación post-doctoral en el
Laboratorio Donner, Grupo de Lipoproteínas y Arterioesclerosis,
en el Departamento de Medicina Nuclear y Molecular de la
División de Ciencias de la Vida, del Laboratorio Lawrence
Berkeley. Universidad de Berkeley, California.
• 1994-1995 Investigadora Asociada, Departamento de Nutrición,
Escuela de Salud Pública de Harvard, Boston.
Nominaciones Académicas
• 1994-2001 Becaria visitante, Instituto de Investigación en
Salud, Universidad de Costa Rica.
• 1995-2001 Profesora Asistente de Nutrición, Escuela de Salud
Pública de Harvard.
• 2001-2006 Profesora Asociada de Nutrición, Escuela de Salud
Pública de Harvard.

• 2001 Investigadora Asociada, Centro Centroamericano de
Población, Universidad de Costa Rica.
• 2006 Catedrática de Nutrición, Escuela de Salud Pública de
Harvard.
Honores y Distinciones Académicas
• 1982 Beca extranjera, Universidad de Mount Holyoke
• 1984 Elizabeth Adams Award en Biología, Universidad de Mount
Holyoke
• 1991 Post Doctoral Research Award, Asociación Americana de
Cardiología
• 1996 Grant-In-Aid Award, Asociación Americana de Cardiología
• 2001 Mujer del Año, Heredia, Costa Rica
• Miembro de la Academia Nacional de Ciencias, Costa Rica
• Pan-American Nutrition, Food Science and Technology Award
Publicaciones
Publicaciones:
1. McNamara JR,Campos H, Ordovas JM, Wilson PWF, Schaefer EJ.
Effect of gender and lipid status on low density lipoprotein
subfraction distribution: Results from the Framingham Offspring
Study. Arteriosclerosis 1987; 7:483-490.
2. Bailey SM, Campos H, Schosinsky K, Mata L. Relationship of
upper body fat distribution to serum glucose and lipids in a Costa
Rican population. Am J Physical Anthrop 1987; 73: 111.
3. McNamara JR, Campos H, Ordovas JM, Wilson PWF, Schaefer EJ.
Gradient gel electrophoretic analysis of low density lipoproteins.
Am Biotech Lab 1988; 6:29-33.
4. Campos H, McNamara JR, Ordovas JR, Wilson PWF, Schaefer EJ.
Differences in low density lipoprotein subfractions and
apolipoproteins in premenopausal and postmenopausal women. J
Clin Endocrinol Metab 1988; 67:30-35.
5. McNamara JR, Campos H, Adolphson JL, Ordovas JM, Wilson PWF,
Albers JJ, Usher DC, Schaefer EJ. Screening for lipoprotein (a)
elevations in plasma and assessment of size heterogeneity by

gradient gel electrophoresis. J Lipid Res 1989; 30:747-755.
6. Campos H, Wilson PWF, Jiménez D, McNamara JR, Ordovas JM,
Schaefer EJ. Differences in apolipoproteins and low density
lipoprotein subfractions in postmenopausal women on and off
estrogen therapy: Results from the Framingham Offspring Study.
Metabolism 1990; 39:1033-1038.
7. Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer
EJ. Relations of body habitus, fitness level, and cardiovascular risk
factors including lipoproteins and apolipoproteins in a rural and
urban Costa Rican population. Arterioscler Thromb 1991; 11:1077-
1088.
8. Campos H, Willett WC, Peterson RM, Siles X, Bailey SM, Wilson
PWF, Posner BM, Ordovas JM, Schaefer EJ. Nutrient intake
comparisons between Framingham and rural and urban Puriscal,
Costa Rica: Associations with lipoproteins, apolipoproteins, and
LDL particle size. Arterioscler Thromb 1991; 11:1089-1099.
9. Campos H, Mata L, Siles X, Vives M, Ordovas JM, Schaefer EJ.
Prevalence of cardiovascular risk factors in rural and urban Costa
Rica. Circulation 1992; 8:648-658.
10. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL,
Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein
particle size and coronary artery disease. Arterioscler Thromb
1992; 12:187-195.
11. Granfone A, Campos H, McNamara JR, Schaefer MM, Lamon-Fava
S, Ordovas JM, Schaefer EJ. Effects of estrogen replacement on
plasma lipoproteins and apolipoproteins in postmenopausal
dyslipidemic women. Metabolism 1992; 4:1193-1198.
12. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM,
Wilson PWF, Castelli WP, Schaefer EJ. Low-density lipoprotein
particle size distribution: Results from the Framingham Offspring
Study. Arterioscler Thromb Vasc Biol 1992; 12:1410-1419.
13. Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss
RM. Differential effects of estrogen on low-density lipoprotein
subclasses in healthy postmenopausal women. Metabolism 1993;
42:1153-1158.

14. Campos H, Dreon DM, Krauss RM. Associations of hepatic and
lipoprotein lipase activities with changes in dietary composition
and low-density lipoprotein subclasses. J. Lipid Res. 1995;
36:462-472.
15. Campos H, Roederer GO, Lussier-Cacan S, Davignon J, Krauss
R.M. Predominance of large LDL and reduced HDL2 cholesterol in
normolipidemic men with coronary artery disease. Arterioscler
Thromb Vasc Biol 1995; 15:1043-1048.
16. Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM.
Altered receptor binding affinity of two forms of large, buoyant
LDL in normolipidemic subjects with predominance of small LDL.
Arterioscler Thromb Vasc Biol 1996; 16:794-801.
17. Campos H, López-Miranda J, Rodríguez C, Albajar M, Schaefer EJ,
Ordovás JM. Urbanization elicits a more atherogenic lipoprotein
profile in carriers of the apolipoprotein A-IV-2 allele compared to
A-IV-1 homozygotes. Arterioscler Thromb Vasc Biol 1997;1
7:1074-1081.
18. Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on
very low-density lipoprotein and low density lipoprotein subclass
metabolism in postmenopausal women. J Clin Endocrinol Metab
1997; 82:3955-3963.
19. Dreon MD, Fernstrom HA, Campos H, Krauss RM. Change in
dietary saturated fat intake is correlated with change in plasma
low-density lipoprotein subclasses and postheparin lipase activities
in men. Am J Clin Nut 1998; 67:828-836.
20. Su W, Campos H, Judge HJ, Walsh BW, Sacks FM. Metabolism of
apo (a) and apoB100 of lipoprotein (a) in women: Effect of
postmenopausal estrogen replacement. J Clin Endocrinol Metab
1998; 83:3267-3276.
21. Khoo C, Campos H, Judge H, Sacks FM. Effects of estrogenic oral
contraceptives on the lipoprotein B particle system defined by
apolipoproteins E and C-III content. J Lipid Res 1999; 40:202-212.
22. Campos, H and Siles X. Siesta and the risk of coronary heart
disease: results from a population-based, case-control study in
Costa Rica. Int J Epidemiol 2000; 29:429-437.

23. Campos H, D’Agostino M, Ordovas JM. Gene-diet interactions and
plasma lipoproteins: Role of apolipoprotein E and habitual
saturated fat intake. Genetic Epidemiol 2000; 20:117 – 128.
24. Irwig MS, Siles X, Gotto AM, Rifai N, Campos H. Plasma lipids and
other cardiovascular risk factors in Costa Rican adolescents. Pan
Am J Public Health 2000; 8:234-241.
25. Sen-Banarjee S, Siles X, and Campos H. Tobacco smoking
modifies association between Gln-Arg192 polymorphism of human
paraoxonase gene and risk of myocardial infarction. Arterioscler
Thromb Vasc Biol 2000;20:2120-2126.
26. Campos H, Perlov D, Khoo C, and Sacks F. Distinct patterns of
lipoproteins with apolipoprotein B defined by presence of
apolipoproteins E or CIII in hypercholesterolemia and
hypertriglyceridemia. J Lipid Res 2001; 42:11239-1249.
27. El-Sohemy E, Baylin A, Kabagambe E, Ascherio A, Spiegelman D,
and Campos H. Population-based study of - and -tocopherol
in plasma and adipose tissue as biomarkers of intake in Costa
Rican adults. Am J Clin Nut 2001; 74:356-363.
28. Campos, H, Moye L, Glasser SP, Stampfer MJ, and Sacks FM. Low
density lipoprotein size, pravastatin treatment and coronary
events. JAMA 2001; 286:1468-1474.
29. Kabagame EK, Baylin A, Allan DA, Siles X, Spiegelman D, Campos
H. Application of the method of triads to evaluate the performance
of food-frequency questionnaires and biomarkers as indicators of
long-term dietary intake. Am J Epidemiol 2001; 154:1126-1135.
30. El-Sohemy A, Baylin A, Ascherio A, Spiegelman D, Campos H.
Dietary and adipose tissue -tocopherol and risk of myocardial
infarction. Epidemiology 2002; 13:216-223.
31. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett
WC, Ma J. Blood long-chain N-3 fatty acids and risk of sudden
cardiac death among men without a history of cardiovascular
disease. N Engl J Med 2002; 346:1113-1118.
32. El-Sohemy A, Baylin A, Kabagambe E, Ascherio A, Spiegelman D,
Campos H. Individual carotenoid concentrations in adipose tissue
and plasma as biomarkers of dietary intake. Am J Clin Nut 2002;

76:172-179.
33. Baylin A, Kabagame EK, Siles X, and Campos H. Adipose tissue
biomarkers of fatty acid intake. Am J Clin Nut 2002; 76:750-757.
34. Irwig MS, El-Sohemy A, Baylin A, Rafai N, Campos H. Frequent
intake of tropical fruits that are rich in b-cryptoxanthin is
associated with higher plasma -cryptoxanthin concentrations in
Costa Rican adolescents. J Nut 2002; 132:3161-3167.
35. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H.
-Linolenic acid in adipose tissue and risk of nonfatal acute
myocardial infarction in Costa Rica. Circulation 2003; 107:1586-
1591.
36. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H.
High 18:2 trans fatty acids are associated with increased risk of
nonfatal acute myocardial infarction in Costa Rican adults. J Nutr
2003; 133:1186-1191.
37. Lee SJ, Campos H, Moye LA, Sacks F. LDL containing apoCIII is
an independent risk factor for recurrent coronary events in
diabetic patients. Arterioscler Thromb Vasc Biol 2003; 23:853-
858.
38. Kim MK, Siles, X. and Campos H. Trans fatty acid intake, plasma
lipoprotein levels and LDL particle size in a Costa Rican population.
Metabolism 2003; 52:693-698.
39. Lee SJ, Moye LA, Campos H, Williams GH, Sacks FM.
Hypertriglyceridemia and hyperglycemia but not diabetes status
are associated with apo B-lipoproteins containing apoC3 in
patients with coronary heart disease Atherosclerosis
2003;167:293-302.
40. Kim MK, Ordovas JM, Selhub J, and Campos H. B vitamins and
plasma homocysteine levels in a rural and urban population of
Costa Rica. J Am Coll Nutr 2003; 22:224-231.
41. Kabagambe EK, Baylin A, Siles X, and Campos H. Individual
saturated fatty acids and nonfatal myocardial infarction in Costa
Rica. Eur J Clin Nutr 2003:57:1447-1457.
42. Brown S, Ordovás JM, and Campos H. Interaction between the

APOC3 gene promoter polymorphisms, saturated fat intake and
plasma lipoproteins. Atherosclerosis 2003; 170:307-313.
43. Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano M, Willett
WC, Ma J. Plasma carotenoids and tocopherols and risk of
myocardial infarction in a low-risk population of US male
physicians. Circulation 2003; 108:802-807.
44. Ruiz-Narvaez E and Campos H. Transmission disequilibrium test
(TDT) for case-control studies. Eur J Hum Genet 2004; 12:105-
114.
45. Furtado J, Siles X, and Campos H. Carotenoid concentrations in
vegetables and fruits common to the Costa Rican diet. Inter J Food
Sci Nutr 2004; 55:101:113.
46. Hak AE, Ma J, Powell CB, Campos H, Gaziano M, Willett WC,
Stampfer MJ. A prospective study of plasma carotenoids and
tocopherols in relation to risk of ischemic stroke. Stroke 2004;
35:1584-1588.
47. Chiuve SE, Martin LA, Campos H, Sacks FM. Effect of the
Combination of methyltestosterone and esterified estrogens
compared with esterified estrogens alone on apolipoprotein CIII,
lipids and lipoproteins in postmenopausal women. J Clin Endocrinol
Metab 2004; 89:2207-2213.
48. Cornelis MC, El-Sohemy A, and Campos H. Genetic polymorphism
of CYP1A2 increases risk of myocardial infarction. J Med Genetics
2004; 41:758-762.
49. Yang Y, Ruiz-Narvaez E, Niu T, Xu X, Campos H. Genetic variants
of the lipoprotein lipase gene and myocardial infarction in the
Central Valley of Costa Rica. J Lipid Res 2004;45:2106-2109.
50. Baylin A and Campos H. Arachidonic acid in adipose tissue is
associated with increased risk of myocardial infarction in the
Central Valley of Costa Rica. J Nutr 2004;134:3095-3099.
51. Kabagambe EK, Baylin A, Irwig MS, Furtado J, Siles X, Kim MK,
Campos H. Costa Rican adolescents have a deleterious
nutritional profile as compared to adults in terms of lower dietary
and plasma concentrations of antioxidant micronutrients. J Am Coll
Nutr 2005; 24:122-8.

52. Tamimi RM, Hankinson SE, Campos H, Spiegelman D, Zhang S,
Colditz GA, Willett WC, Hunter DJ. Plasma carotenoids, retinol, and
tocopherols and risk of breast cancer.
Am J Epidemiol. 2005; 161:153-60.
53. Kabagambe, EK, Baylin A, Ruiz-Narvarez E, Siles X, Campos H.
Decreased consumption of dried mature beans is positively
associated with urbanization and nonfatal acute myocardial
infarction. J Nutr 2005; 5:1770-1775.
54. Kabagambe EK, Baylin A, Furtado J, Campos H. Dietary and
adipose tissue antioxidants and risk of nonfatal acute myocardial
infarction in Costa Rica J Nutr 2005; 5: 1763-1769.
55. Campos H, Khoo C, and Sacks FM. Diurnal and acute patterns of
postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from
normolipidemic humans. Atherosclerosis 2005; 181:345-351.
56. Baylin A, Kim MK, Donovan-Palmer A, Siles X, Dougherty L, Tocco
P, Campos H. Fasting whole blood can be a suitable readily
available biomarker of essential fatty acid intake in epidemiologic
studies: comparison with adipose tissue, plasma, and red blood
cells from Costa Rican adults. Am J Epidemiol 2005;1621:373-
381.
57. Monge-Rojas R, Campos H, Fernández-Rojas X. Saturated and
cis- and trans-unsaturated fatty acid intake in rural and urban
Costa Rican adolescents J Am Coll Nutr 2005; 24:286-293.
58. Ruiz-Narvarez E, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H.
APOC3 and APOA5 haplotypes, plasma lipids and risk of
myocardial infarction in the Central Valley of Costa Rica J Lipid Res
2005;46:2605-2613.
59. Kabagambe EK, Baylin A, Ascherio A, Campos H. Type of oil used
for cooking is associated with risk of myocardial infarction in a
Costa Rican Population. J Nutr 2005 135:2674-2679.
60. Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC,
Winer EP, Enzinger, PC, Bunnell CA, Kulke MH, Fuchs, CS.
Assessment of a dietary questionnaire in cancer patients receiving
cytotoxic chemotherapy. J Clin Oncol 2005;23:8453-8460

61. Kabagambe EK, Baylin A, Ruiz-Narvaez E, Rimm EB, Campos H.
Alcohol intake, drinking patterns and risk of nonfatal acute
myocardial infarction in Costa Rica. Am J Clin Nut 2005; 82:1336-
1345.
62. Martínez-Ortiz JA, Fung TT, Baylin A, Hu FB, Campos H. Dietary
patterns and risk of nonfatal acute myocardial infarction in Costa
Rican adults. Eur J Clin Nutr 2006.
63. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee,
CYP1A2 genotype and risk of myocardial infarction. JAMA 2006;
295:1135-1141.
64. Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB,
Hotamisligil GS. A genetic variant at the fatty acid-binding protein
aP2 locus reduces the risk for hypertriglyceridemia, type 2
diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A.
2006;103:6970-5
65. Gold DR, Willwerth BM, Tantisira KG, Finn PW, Schaub B, Perkins
DL, Tzianabos A, Ly NP, Schroeter C, Gibbons F, Campos H, Oken
E, Gillman MW, Palmer LJ, Ryan LM, Weiss ST.. Associations of
cord blood fatty acids with lymphocyte proliferation, IL-13, and
IFN-gamma. J Allergy Clin Immunol. 2006; 4:931-8.
66. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles S, Campos H.
Transient exposure to coffee as a trigger of a first nonfatal
myocardial infarction. Epidemiology. 2006; 17:506-11.
67. Colon-Ramos U, Baylin A, Campos H. The relation between trans
fatty acid levels and increased risk of myocardial infarction does
not hold at lower levels of trans fatty acids in the Costa Rican food
supply. J Nutr. 2006; 136:2887-92.
68. Iakoubova OA, Tong CH, Chokkalingam AP, Rowland CM,
Kirchgessner TG, Louie JZ, Ploughman LM, Sabatine MS, Campos
H, Catanese JJ, Leong DU, Young BA, Lew D, Tsuchihashi Z, Luke
MM, Packard CJ, Zerba KE, Shaw PM, Shepherd J, Devlin JJ, Sacks
FM. Asp92Asn polymorphism in the myeloid IgA Fc receptor is
associated with myocardial infarction in two disparate populations:
CARE and WOSCOPS. Arterioscler Thromb Vasc Biol. 2006;
26:2763-8.
69. McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G,

Schmitz HH, Coletti C, Campos H, Hollenberg NK. Hypertension,
the Kuna, and the epidemiology of flavanols.
J Cardiovasc Pharmacol. 2006; 47 Suppl 2:S103-9.
70. Baylin A, Ruiz-Narvaez E, Kraft P, Campos H. Alpha-linolenic acid,
Δ6 desaturase gene polymorphism, and risk of nonfatal myocardial
infarction, J Clin Nutr 2007:85:554.
71. Baylin A, Siles X, Donovan-Palmer A, Fernandez X, Campos H.
Fatty acid composition of Costa Rican foods including trans fatty
acid content. J Food Comp and Analysis 2007; 20:182.
72. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles S, Campos H.
Triggers of nonfatal myocardial infarction in Costa Rica: heavy
physical exertion, sexual activity, and infections. Ann of Epidemiol
2007; 17:112.
73. Kabagambe E, Baylin A, Campos H. Nonfatal acute myocardial
infarction in Costa Rica: Modifiable risk factors, population
attributable risks and adherence to dietary guidelines. Circulation
2007; 115:1075-81.
74. Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, Willett WC, Ma
J. Blood levels of long-chain polyunsaturated fatty acids, aspirin,
and the risk of colorectal cancer. Cancer Epidemiol Biomarkers
Prev. 2007; 16:314-21.
75. Mozaffarian D, Abdollahi M, Campos H, HoushiarRad A, Willett WC
Consumption of Trans Fats and Estimated Effects on Coronary
Heart Disease in Iran. Eur J Clin Nutr. 2007; 61:1004-1010.
76. Holmes MD, Powell IJ, Campos H, Stampfer MJ, Giovannucci EL,
Willett WC. Validation of a food frequency questionnaire
measurement of selected nutrients using biological markers in
African-American men. Eur J Clin Nutr. 2007; 61:1328-36
77. Cornelis, MC, El-Sohemy, A, Campos, H. Microsomal Epoxide
Hydrolase Genotype and Risk of Myocardial Infarction Arch Toxicol.
2007; 81:641-5.
78. Sun Q, Ma J, Campos H, Hankinson SE, Manson JE, Stampfer MJ,
Rexrode KM, Willett WC, Hu FB. A Prospective Study of Trans Fatty
Acids in Erythrocytes and Risk of Coronary Heart Disease.
Circulation. 2007; 115:1858-65.

79. Colon-Ramos U, Kabagambe E, Ascherio A, Baylin A, Peterson KE,
Campos H. Socioeconomic status and health awareness are
associated with choice of cooking oil in Costa Rica. Public Health
Nutr. 2007; 29:1-9.
80. Williams ES, Baylin A, Campos H. Adipose tissue arachidonic acid
and the metabolic syndrome in Costa Rican adults. Clin Nutr.
2007; 26:474-82.
81. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A
prospective study of polyunsaturated fatty acid levels in blood and
prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;
16:1364-70.
82. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison
between plasma and erythrocyte fatty acid content as biomarkers
of fatty acid intake in US women. Am J Clin Nutr. 2007; 86:74-81.
83. Cornelis, MC, El-Sohemy, A, Campos, H. Genetic Polymorphism of
the Adenosine A2A Receptor Affects Habitual Caffeine Consumption.
Am J Clin Nutr. 2007; 86:240-4.
84. Villamor E, Koulinska IN, Furtado J, Baylin A, Aboud S, Manji K,
Campos H, Fawzi WW. Long-chain n 6 polyunsaturated fatty acids
in breast milk decrease the risk of HIV transmission through
breastfeeding. Am J Clin Nutr. 2007; 86:682-9.
85. Cornelis, MC, El-Sohemy, A, Campos, H. GSTT1 Genotype
Modifies the Effect of Cruciferous Vegetable Intake on Risk of
Myocardial Infarction. Am J Clin Nutr. 2007; 86:752-8.
86. Ruiz-Narváez EA, Kraft P, Campos H. Ala12 variant of the
peroxisome proliferator-activated receptor-gamma gene (PPARG)
is associated with higher polyunsaturated fat in adipose tissue and
attenuates the protective effect of polyunsaturated fat intake on
the risk of myocardial infarction. Am J Clin Nutr. 2007; 86:1238-
42.
87. Sun Q, Ma J, Campos H, Hu FB. Plasma and erythrocyte
biomarkers of dairy fat intake and risk of ischemic heart disease.
Am J Clin Nutr. 2007; 86:929-37.
88. Zatonski W, Campos H, Willett W. Rapid declines in coronary

heart disease mortality in Eastern Europe are associated with
increased consumption of oils rich in alpha-linolenic acid. Eur J
Epidemiol. 2008; 23:3-10.
89. Colón-Ramos U, Lindsay AC, Monge-Rojas R, Greaney ML,
Campos H, Peterson KE. Translating research into action: a case
study on trans fatty acid research and nutrition policy in Costa
Rica. Health Policy Plan. 2007 22:363-74.
90. Yang Y, Ruiz-Narvaez E, Kraft P, Xu X, Campos H. Effect of
apolipoprotein E genotype and saturated fat intake on plasma lipid
levels and risk of myocardial infarction in the Central Valley of
Costa Rica. Hum Biol. 2007; 79:637-47.
91. Sabatine MS, Ploughman L, Simonsen KL, Iakoubova OA,
Kirchgessner TG, Ranade K, Tsuchihashi Z, Zerba KE, Long DU,
Tong CH, Packard CJ, Pfeffer MA, Dracopoli NC, Devlin JJ,
Shepherd J, Campos H, Sacks FM, Braunwald E. Association
Between ADAMTS1 Matrix Metalloproteinase Gene Variation,
Coronary Heart Disease, and Benefit of Statin Therapy.
Arterioscler Thromb Vasc Biol. 2008 28:562-7
92. Ruiz-Narváez EA, Campos H. Evolutionary rate heterogeneity of
Alu repeats upstream of the APOA5 gene: do they regulate APOA5
expression? J Hum Genet. 2008; 53:247-53.
93. Chavarro JE, Stampfer MJ, Campos H, Kurth T, Willett WC, Ma J.
A prospective study of trans-Fatty Acid levels in blood and risk of
prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17:95-
101.
94. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA,
Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ,
Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, Sacks
FM. Association of the Trp719Arg polymorphism in kinesin-like
protein 6 with myocardial infarction and coronary heart disease in
2 prospective trials: the CARE and WOSCOPS trials. J Am Coll
Cardiol. 2008; 51:435-43.
95. Ruiz-Narváez EA, Sacks FM, Campos H. Abdominal obesity and
hyperglycemia mask the effect of a common APOC3 haplotype on
the risk of myocardial infarction. Am J Clin Nutr. 2008; 87:1932-8.
96. Furtado JD, Campos H, Appel LJ, Miller ER, Laranjo N, Carey VJ,

Sacks FM. Effect of protein, unsaturated fat, and carbohydrate
intakes on plasma apolipoprotein B and VLDL and LDL containing
apolipoprotein C-III: results from the Omni Heart Trial. Am J Clin
Nutr. 2008 Jun; 87(6):1623-30.
97. Allayee H, Baylin A, Hartiala A, Wijesuriya H, Mehrabian M, Lusis
AJ, Campos H. Nutri-genetic association of the 5-lipoxygenase
gene with myocardial infarction Am J Clin Nutr 2008;88:934-40.
98. Campos H, Baylin A, Willett, WC. α–Linolenic acid and risk of
nonfatal acute myocardial infarction. Circulation 2008; 118:339-
345.
99. Sun Q, Ma J, Campos H, Rexrode KM, Albert CM, Mozaffarian D,
Hu FB. Blood concentrations of individual long-chain n-3 fatty
acids and risk of nonfatal myocardial infarction. Am J Clin Nutr.
2008; 88:216-23.
100. DiBello JR, Kraft P, McGarvey ST, Goldberg R, Campos H, Baylin
A. Comparison of 3 methods for identifying dietary patterns
associated with risk of disease. Am J Epidemiol. 2008; 168:1433-
43.
101. Webb AL, Aboud S, Furtado J, Murrin C, Campos H, Fawzi WW,
Villamor E. Effect of vitamin supplementation on breast milk
concentrations of retinol, carotenoids and tocopherols in HIVinfected
Tanzanian women. Eur J Clin Nutr. 2009; 63:332-9.
102. Baylin A, Mora-Plazas M, Cobos-de Rangel O, Lopez-Arana S,
Campos H, Villamor E. Predictors of usage and fatty acid
composition of cooking fats in Bogotá, Colombia. Public Health
Nutr. 2009; 12:531-7.
103. Truong H, DiBello JR, Ruiz-Narvaez E, Kraft P, Campos H, Baylin
A. Does genetic variation in the Delta6-desaturase promoter
modify the association between alpha-linolenic acid and the
prevalence of metabolic syndrome? Am J Clin Nutr. 2009; 89:920-
5.
104. Baylin A, Ruiz-Narváez E, Jensen MK, Rimm E, Campos
H. Association between hepatic lipase -514 C/T promoter
polymorphism and myocardial infarction is modified by history of
hypercholesterolemia and waist circumference. Nutr Metab
Cardiovasc Dis. 2009 Aug 18. [Epub ahead of print]

105. Dibello JR, McGarvey ST, Kraft P, Goldberg R, Campos H,
Quested C, Laumoli TS, Baylin A. Dietary Patterns Are Associated
with Metabolic Syndrome in Adult Samoans. J Nutr. 2009 Aug 26.
[Epub ahead of print]
Otras publicaciones (Editoriales, comentarios, capítulos en
libros, revisions de la literatura).
1. Sacks FM, Campos H, Judge H, Walsh BW. Estrogen treatment
and human lipoprotein metabolism. In Hormonal, Metabolic, and
Cellular Influences on Cardiovascular Disease in Women. T.
Forte, editor. Futura/Armonk, New York. 1998, 71-83.
2. Campos H. Gene-diet interactions, plasma lipoproteins, and
coronary heart disease: potential role of the apoAI-CIII-AIV gene
cluster. Aust J Nutr Diet 1998; 55(4 Suppl) S12-S15.
3. Campos H. The Latin American Diet Pyramid: A healthy
foundation. In Healthy Latin Cooking. Steven Raichlen. Rodale
Press, Emmaus, Pensylvania 1998. [Also published in Spanish: La
Pirámide Dietética Latinoamericana: un fundamento sano. En
Salud y Sazón].
4. Campos H. Siesta and myocardial infarction [letter] Int J
Epidemiol 2000; 30-183-184.
5. Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV,
Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Eckel
RH, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke
MA, Howard BV, Kennedy E, Krauss RM, Kris-Etherton P,
Lichtenstein AH, Marckmann P, Pearson TA, Riccardi G, Rudel LL,
Rudrum M, Sacks F, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock
PL, Bazzarre TL, Clark J. Summary of the scientific conference on
dietary fatty acids and cardiovascular health: conference summary
from the nutrition committee of the American Heart Association:
Circulation 2001;20:103:1034-9
6. Campos H, Sacks FM. In reply –Is the size of low-density
lipoprotein particles related to the risk of coronary heart disease?
[letter] JAMA 2002; 287:712-713.
7. Kabagambe E, Baylin A, Campos H. Comparison of dietary
intakes of micro- and macronutrients in rural, suburban and urban

populations of Costa Rica. Pub Health Nut 2002; 5(6A):835-842.
8. Sacks and Campos H. LDL size and heart disease. [Clinical
Review] J Clin Endocrinol Metab 2003; 88:4525-4532.
9. Baylin A and Campos H. Fatty acid biomarkers of dietary intake
Curr Opin Lipidol 2006; 17:22-27.
10. Sacks and Campos H. Polyunsaturated fatty acids, inflammation
and cardiovascular disease: time to widen our view of the
mechanisms J Clin Endocrinol Metab 2006; 91:398-400.
11. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles X, Campos H.
Coffee and Myocardial Infarction. Epidemiology [letter]. 2007;
18:282-283.
12. Campos H, Baylin A. Coffee consumption and risk of type 2
diabetes and heart disease. Nutr Rev. 2007 Apr; 65(4):173-9.
Review
13. El-Sohemy A, Cornelis MC, Kabagambe EK, Campos H. Coffee,
CYP1A2 genotype and risk of myocardial infarction. Genes Nutr.
2007 Oct; 2(1):155-6.
14. The HEM project team edited by Witold Zatonski Closing the
health gap in European Union. Cancer Epidemiology and
Prevention Division, the Maria Sklodowska-Curie Memorial Cancer
Center and Institute of Oncology, Warsaw, Poland, 2008. Dr.
Campos was principal co-investigator and actively participated in
preparing the individual reports, scientific papers and the
Blueprint.